+1,011.8%
MRNA vs CG
+186.4%
+825.4%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -1.1% | -2.8% | -3.6% |
| 7D | -17.6% | -7.6% | -10.0% | -15.2% |
| 30D | -5.1% | +5.9% | -11.1% | -7.0% |
| 3M | +220.8% | -20.6% | +241.4% | +248.3% |
| 6M | +321.7% | -18.6% | +340.3% | +351.7% |
| YTD | +601.3% | -33.4% | +634.7% | +695.8% |
| 1Y | +735.2% | -23.4% | +758.6% | +810.6% |
| 3Y | +170.5% | +32.4% | +138.2% | +156.5% |
| 5Y | -14.6% | -23.9% | +9.3% | -17.5% |
| All | +1,011.8% | +186.4% | +825.4% | +882.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CG.
Daily Out/Under-Performance
Portfolio return minus CG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling